Orrick announced today that the premier patent litigation team of Richard DeLucia, Elizabeth Gardner, A. Antony Pfeffer and K. Patrick Herman has joined the firm’s Patent Litigation group, all resident in New York. The team brings deep experience in all types of IP litigation with a particular focus on patent litigation representing leading companies in the biotech, pharmaceutical and medical device industries.
"We are honored to add this top-caliber trial team to our NY IP bench," said Alex Chachkes, co-leader of the firm’s Patent Litigation practice. "They bring a formidable record at trial, deep experience with inter partes reviews and strong technical credentials."
"Orrick offers a terrific platform for our clients and our practice. It is a powerhouse litigation firm with an IP team that we have long admired and a strong focus on tech." Richard said. "We look forward to working with our new colleagues to build on this success and expand the firm’s practice in the life sciences sector."
"This is one of the go-to teams for life sciences companies. Their expertise, coupled with our recent addition of life sciences, product liability and commercial litigator Kathy O’Connor, enhances Orrick’s position as a premier law firm to which companies in the industry turn to with their most troubling problems," noted Rob Reznick, who co-leads Orrick's Life Sciences practice.
The group joins from Kenyon & Kenyon.
Richard, who joins as a partner, is a widely recognized first-chair trial lawyer who has served as chief trial counsel in over 100 cases, including numerous bet-the-company cases. Chambers USA wrote about him: “He is a ‘confident and strategic’ player who ‘simply wins a lot.’” Known for his effective courtroom style, he advises on licensing, validity, enforceability, and infringement of patents, trademarks and copyrights. Richard is recognized as a leader in patent law by Chambers USA, Legal 500 US, Managing IP, Legal Media Group’s Guide to the World’s Leading Patent Law Experts, Best Lawyers in America and New York Super Lawyers.
Elizabeth, who joins as a partner, represents clients in all phases of litigation involving patented and trade secret protected technology in the chemical, materials, pharmaceutical, electrical, medical products and medical diagnostics industries. She has represented clients in numerous trials and other proceedings in the Federal district courts, the International Trade Commission, the U.S. Court of Appeals for the Federal Circuit and the US Patent and Trademark Office. Elizabeth has been named an IP Star by Managing IP in each of the past three years.
Antony, who joins as a partner, focuses his practice on patent infringement and trade secret misappropriation litigation, as well as patent office proceedings such as IPRs. In addition to helping clients resolve disputes, he handles transactional and licensing work on commercial collaborations, joint research arrangements and a diverse range of other transactions. Antony’s work has involved a broad range of technologies including biotechnology, pharmaceuticals, consumer electronics, medical devices and automotive technologies. He is a member of Law360’s Intellectual Property Editorial Advisory Board.
Patrick, who joins as of counsel, has led numerous successful IPR petitions and prevailed on several at trial. In addition to his IPR work, he also represents clients on complex patent and IP litigation at both the district court and appellate levels. Patrick has been involved in cases implicating a broad range of technologies, including the medical device, pharmaceutical, petrochemical, automotive, consumer electronics and children’s toy industries. He was named a Rising Star in the 2014 and 2015 editions of New York Super Lawyers.
Orrick’s IP Team
In December, Orrick was named IP Litigation Department of the Year by American Lawyer for 2015. The firm was also selected as a Law360 IP Group of the Year and as an IP All-Star for being one of four firms most often recognized for its IP achievements over the past five years. The firm’s IP litigation team comprises 125 lawyers globally, including first-chair trial lawyers and qualified scientists and engineers who have handled more than 675 patent litigation cases in the last 10 years.
These moves continue Orrick's strategic growth of its IP and Life Sciences litigation practice. During 2015, the firm added Kathy O’Connor from Weil Gotshal to its NY life sciences team, and both Patrick Ellisen, formerly with Greenberg Traurig, and Amy Van Zant, formerly with Covington & Burling, to its Silicon Valley office.